Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Solian Solution to Treat Schizophrenic Patients During an Acute Episode

NCT00245674 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00245674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00245674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Solian Solution to Treat Schizophrenic Patients During an Acute Episode
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
Not reported
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia